Repligen
RGEN
Repligen (RGEN) earnings history
Most recent quarter
- Fiscal period
- Q2 2026
- Period end
- Jun 30, 2026
- EPS actual
- $0.54
- EPS estimate
- $0.45
- EPS surprise
- +20.72%
- Revenue surprise
- +1.26%
- Revenue
- $204.1M
- Revenue estimate
- $201.6M
- Reported
- Jul 28, 2026
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q2 2026 | Jul 28, 2026 | $0.45 | $0.54 | +20.72% | $204.1M | SEC |
| Q1 2026 | May 5, 2026 | $0.38 | $0.48 | +25.03% | $194.3M | SEC |
| Q4 2025 | Feb 24, 2026 | $0.44 | $0.49 | +11.06% | $197.9M | SEC |
| Q3 2025 | Oct 28, 2025 | $0.42 | $0.46 | +9.11% | $188.8M | SEC |
| Q2 2025 | Jul 29, 2025 | $0.39 | $0.37 | −4.69% | $182.4M | SEC |
| Q1 2025 | Apr 29, 2025 | $0.35 | $0.39 | +12.68% | $169.2M | SEC |
| Q4 2024 | Feb 20, 2025 | $0.41 | $0.44 | +7.24% | $167.5M | SEC |
| Q3 2024 | Nov 12, 2024 | $0.34 | $0.43 | +28.21% | $154.9M | SEC |
| Q2 2024 | Jul 30, 2024 | $0.33 | $0.33 | +1.20% | $154.1M | SEC |
| Q1 2024 | May 1, 2024 | $0.30 | $0.28 | −6.98% | $151.3M | SEC |
| Q4 2023 | Feb 21, 2024 | $0.33 | $0.33 | +1.29% | $155.7M | SEC |
| Q3 2023 | Oct 31, 2023 | $0.16 | $0.23 | +39.48% | $141.2M | SEC |
| Q2 2023 | Aug 2, 2023 | $0.48 | $0.53 | +11.56% | $159.2M | SEC |
| Q1 2023 | May 2, 2023 | $0.59 | $0.64 | +8.79% | $182.7M | SEC |
| Q4 2022 | Feb 22, 2023 | $0.58 | $0.68 | +17.93% | $186.8M | SEC |
| Q3 2022 | Nov 1, 2022 | $0.68 | $0.77 | +13.25% | $200.7M | SEC |
| Q2 2022 | Aug 2, 2022 | $0.71 | $0.91 | +27.49% | $207.6M | SEC |
| Q1 2022 | Apr 27, 2022 | $0.72 | $0.92 | +27.78% | $206.4M | SEC |
| Q4 2021 | Feb 17, 2022 | $0.65 | $0.81 | +24.85% | $186.5M | SEC |
| Q3 2021 | Oct 28, 2021 | $0.64 | $0.78 | +22.47% | $178.2M | SEC |
Quarterly revenue
Frequently asked questions
When did Repligen (RGEN) last report earnings?
Repligen last reported on Jul 28, 2026, covering fiscal Q2 2026.
Did RGEN beat earnings estimates?
Yes. Repligen reported EPS of $0.54 for Q2 2026 against a $0.45 estimate — a 20.72% beat.
How much revenue did RGEN report last quarter?
Repligen reported $204.1M in revenue for Q2 2026, against a consensus estimate of $201.6M.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.